6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling

Details for Australian Patent Application No. 2007237904 (hide)

Owner Novartis AG

Inventors Sharma, Anu; Ramurthy, Savithri; Wagman, Allan; Klivansky, Liana M.; Sendzik, Martin; Wang, Weibo; Ng, Simon C.; Lenahan, William P.; Pfister, Keith; Mieuli, Elizabeth J.; Lan, Jiong; Sung, Victoria; Kaufman, Susan; Yang, Hong; Wiesmann, Marion; Lindvall, Mika K.; Sutton, James C.

Agent Davies Collison Cave

Pub. Number AU-B-2007237904

PCT Pub. Number WO2007/121484

Priority 60/893,857 08.03.07 US; 60/793,517 19.04.06 US

Filing date 18 April 2007

Wipo publication date 25 October 2007

Acceptance publication date 3 March 2011

International Classifications

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/44 (2006.01) - Non-condensed pyridines

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 35/00 (2006.01) Antineoplastic agents

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

16 October 2008 PCT application entered the National Phase

  PCT publication WO2007/121484 Priority application(s): WO2007/121484

3 March 2011 Application Accepted

  Published as AU-B-2007237904

30 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007237905-Intraocular pressure attenuation device

2007237903-Pre-mixed, ready-to-use iv bolus compositions and methods of use